Reaction #1055631

ord-1df7a875897645eca9f8ceb64e7186e6

Solvents

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    workup.STIRRINGstirred for an additional 31 h
  2. 2
    OtherThe solvent was removed under reduced pressure
  3. 3
    Otherthe residue was chromatographed on a short silica column
  4. 4
    Washeluting with 5% methanol in dichloromethane
  5. 5
    OtherThe product obtained
  6. 6
    Otherprecipitated with ether
  7. 7
    FiltrationThe red solid was filtered
  8. 8
    Washrinsed with ether
  9. 9
    Otherdried under vacuum at room temperature

Procedure

A mixture of doxorubicin hydrochloride (58.5 mg, 0.10 mmol), phosphorylating agent (26.7 mg, 0.12 mmol) and diisopropylethylamine (45.5 μL, 0.26 mmol) in 3.0 mL of DMF was stirred for 19 h at room temperature. Treated with additional diisopropylethylamine (60 μL, 0.34 mmol) and phosphorylating agent (31.8 mg, 0.14 mmol) and stirred for an additional 31 h. The solvent was removed under reduced pressure and the residue was chromatographed on a short silica column eluting with 5% methanol in dichloromethane. The product obtained was treated with CH3OH/CH2Cl2 and precipitated with ether. The red solid was filtered, rinsed with ether and dried under vacuum at room temperature.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07303739B2uspto-grants-2007_12